Clinical trial
Celecoxib Versus Diclofenac In The Treatment Of Osteoarthritis Of The Hip
NCT00174317 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00174317 |
|---|---|
| Title | Celecoxib Versus Diclofenac In The Treatment Of Osteoarthritis Of The Hip |
| Official title | Clinical Protocol For A Multicentre, Double-Blind, Randomised, Parallel Group Study To Compare The Efficacy and Tolerability Of Celecoxib Vs. Diclofenac In The Treatment Of Subjects With Osteoarthritis Of The Hip Requiring Joint Replacement Therapy |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Osteoarthritis, Hip |
| Intervention type | Drug |
| Interventions | Celecoxib, Diclofenac |
| Enrollment | 250 |
| Start date | Aug 1, 2003 |
| Completion | Feb 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | Dec 5, 2006 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: